Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 228

1.

Efficacy of etanercept in the treatment of acute, severe sciatica: a pilot study.

Genevay S, Stingelin S, Gabay C.

Ann Rheum Dis. 2004 Sep;63(9):1120-3. Epub 2004 Apr 28.

2.

A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis.

Bliddal H, Terslev L, Qvistgaard E, Konig M, Holm CC, Rogind H, Boesen M, Danneskiold-Samsøe B, Torp-Pedersen S.

Scand J Rheumatol. 2006 Sep-Oct;35(5):341-5.

PMID:
17062431
3.

Epidural administration of spinal nerves with the tumor necrosis factor-alpha inhibitor, etanercept, compared with dexamethasone for treatment of sciatica in patients with lumbar spinal stenosis: a prospective randomized study.

Ohtori S, Miyagi M, Eguchi Y, Inoue G, Orita S, Ochiai N, Kishida S, Kuniyoshi K, Nakamura J, Aoki Y, Ishikawa T, Arai G, Kamoda H, Suzuki M, Takaso M, Furuya T, Toyone T, Takahashi K.

Spine (Phila Pa 1976). 2012 Mar 15;37(6):439-44. doi: 10.1097/BRS.0b013e318238af83.

PMID:
22020607
5.

Tumor necrosis alpha-blocking agent (etanercept): a triple blind randomized controlled trial of its use in treatment of sciatica.

Okoro T, Tafazal SI, Longworth S, Sell PJ.

J Spinal Disord Tech. 2010 Feb;23(1):74-7. doi: 10.1097/BSD.0b013e31819afdc4.

PMID:
20072036
6.

Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept.

Brandt J, Khariouzov A, Listing J, Haibel H, Sörensen H, Rudwaleit M, Sieper J, Braun J.

J Rheumatol. 2004 Mar;31(3):531-8.

PMID:
14994401
7.

Tumor necrosis factor-alpha monoclonal antibody, infliximab, used to manage severe sciatica.

Karppinen J, Korhonen T, Malmivaara A, Paimela L, Kyllönen E, Lindgren KA, Rantanen P, Tervonen O, Niinimäki J, Seitsalo S, Hurri H.

Spine (Phila Pa 1976). 2003 Apr 15;28(8):750-3; discussion 753-4.

PMID:
12698115
8.

The treatment of disc-herniation-induced sciatica with infliximab: one-year follow-up results of FIRST II, a randomized controlled trial.

Korhonen T, Karppinen J, Paimela L, Malmivaara A, Lindgren KA, Bowman C, Hammond A, Kirkham B, Järvinen S, Niinimäki J, Veeger N, Haapea M, Torkki M, Tervonen O, Seitsalo S, Hurri H.

Spine (Phila Pa 1976). 2006 Nov 15;31(24):2759-66.

PMID:
17108825
9.

A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects.

Martínez-Taboada VM, Rodríguez-Valverde V, Carreño L, López-Longo J, Figueroa M, Belzunegui J, Mola EM, Bonilla G.

Ann Rheum Dis. 2008 May;67(5):625-30. Epub 2007 Dec 17.

PMID:
18086726
10.

[Clinical experience with TNF-alpha inhibitors in rheumatoid arthritis].

Wallenius M, Rødevand E, Skomsvoll JF.

Tidsskr Nor Laegeforen. 2005 Jun 16;125(12):1664-6. Norwegian.

11.

Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability.

Baumgartner SW, Fleischmann RM, Moreland LW, Schiff MH, Markenson J, Whitmore JB.

J Rheumatol. 2004 Aug;31(8):1532-7.

PMID:
15290731
12.

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.

13.
14.

Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.

Brandt J, Listing J, Haibel H, Sörensen H, Schwebig A, Rudwaleit M, Sieper J, Braun J.

Rheumatology (Oxford). 2005 Mar;44(3):342-8. Epub 2004 Nov 23. Erratum in: Rheumatology (Oxford). 2005 Apr;44(4):569.

PMID:
15561737
15.

Decreased pain and synovial inflammation after etanercept therapy in patients with reactive and undifferentiated arthritis: an open-label trial.

Flagg SD, Meador R, Hsia E, Kitumnuaypong T, Schumacher HR Jr.

Arthritis Rheum. 2005 Aug 15;53(4):613-7.

16.

Effect of etanercept, a tumor necrosis factor-alpha inhibitor, on neuropathic pain in the rat chronic constriction injury model.

Zanella JM, Burright EN, Hildebrand K, Hobot C, Cox M, Christoferson L, McKay WF.

Spine (Phila Pa 1976). 2008 Feb 1;33(3):227-34. doi: 10.1097/BRS.0b013e318162340a.

PMID:
18303453
17.

Short-term efficacy of intravenous pulse glucocorticoids in acute discogenic sciatica. A randomized controlled trial.

Finckh A, Zufferey P, Schurch MA, Balagué F, Waldburger M, So AK.

Spine (Phila Pa 1976). 2006 Feb 15;31(4):377-81.

PMID:
16481946
18.

Epidural steroids, etanercept, or saline in subacute sciatica: a multicenter, randomized trial.

Cohen SP, White RL, Kurihara C, Larkin TM, Chang A, Griffith SR, Gilligan C, Larkin R, Morlando B, Pasquina PF, Yaksh TL, Nguyen C.

Ann Intern Med. 2012 Apr 17;156(8):551-9. doi: 10.7326/0003-4819-156-8-201204170-00002.

PMID:
22508732
19.

Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study.

Matteson EL, Choi HK, Poe DS, Wise C, Lowe VJ, McDonald TJ, Rahman MU.

Arthritis Rheum. 2005 Jun 15;53(3):337-42.

20.

Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial.

van Riel PL, Freundlich B, MacPeek D, Pedersen R, Foehl JR, Singh A; ADORE Study Investigators.

Ann Rheum Dis. 2008 Aug;67(8):1104-10. Epub 2007 Jul 31.

PMID:
17666447

Supplemental Content

Support Center